[Efficiency treatment of new cases of destructive pulmonary tuberculosis in the presence of concurrent iron deficiency anemia].
A hundred and twenty nine new cases of destructive pulmonary tuberculosis were examined. Of them, 95 patients were diagnosed as having first-degree iron deficiency anemia. Anemia was found to have a negative impact on the clinical efficiency of therapeutical measures. For correction of anemia, the use of antioxidants (tocopherol acetate, ascorbic acid) and an antihypoxant (riboxine) yielded better clinical results than did an iron-containing agent (ferroplex). These results were mostly close to those obtained in a group of patients without anemia.